Raid Aljumaily Selected Research

Raid Aljumaily Research Topics

Disease

10	Neoplasms (Cancer) 01/2021 - 04/2013
4	Disease Progression 10/2020 - 06/2011
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 11/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2014
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 01/2021
2	Anemia 01/2021 - 01/2014
2	Neutropenia 01/2021 - 01/2014
2	Carcinoma (Carcinomatosis) 10/2020 - 01/2018
2	Fatigue 11/2019 - 01/2018
2	Thrombocytopenia (Thrombopenia) 11/2019 - 01/2014
2	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 04/2013
2	Pneumonia (Pneumonitis) 01/2018 - 01/2014
1	Multiple Myeloma 01/2022
1	Residual Neoplasm 01/2022
1	Adenocarcinoma 01/2021
1	Renal Insufficiency (Renal Failure) 10/2020
1	Neoplasm Metastasis (Metastasis) 10/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2020
1	Small Cell Carcinoma 11/2019
1	Communicable Diseases (Infectious Diseases) 11/2019
1	Obesity 01/2019
1	Asthenia 01/2018
1	Fever (Fevers) 01/2014
1	Esophagitis 01/2014
1	Neoplasm Micrometastasis 01/2014
1	Radiation Pneumonitis 01/2014
1	Pain (Aches) 06/2011
1	Glandular and Epithelial Neoplasms (Neoplasms, Glandular) 06/2011
1	Prostatic Neoplasms (Prostate Cancer) 06/2011

Drug/Important Bio-Agent (IBA)

3	pegilodecakinIBA 01/2021 - 11/2019
2	Monoclonal AntibodiesIBA 01/2021 - 04/2013
2	trilaciclibIBA 01/2021 - 01/2021
2	Immunoglobulin G (IgG)IBA 12/2020 - 04/2013
2	PlatinumIBA 10/2020 - 01/2018
2	avelumabIBA 10/2020 - 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Leucovorin (Folinic Acid)FDA Link 01/2021
1	2- (3- (2- (1- isopropyl- 3- methyl- 1H- 1,2- 4- triazol- 5- yl)- 5,6- dihydrobenzo(f)imidazo(1,2- d)(1,4)oxazepin- 9- yl)- 1H- pyrazol- 1- yl)- 2- methylpropanamideIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	cemiplimabIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2021
1	Cetuximab (Erbitux)FDA Link 01/2021
1	Pemetrexed (MTA)FDA Link 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 01/2021
1	prexasertibIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 12/2020
1	GlucocorticoidsIBA 12/2020
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 12/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 10/2020
1	AntibodiesIBA 10/2020
1	LigandsIBA 10/2020
1	AlbuminsIBA 10/2020
1	NivolumabIBA 11/2019
1	pembrolizumabIBA 11/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	navicixizumabIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	LeptinIBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	B7-H1 AntigenIBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	Lipase (Acid Lipase)FDA Link 01/2018
1	Carboplatin (JM8)FDA LinkGeneric 01/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2014
1	Gemcitabine FDA Link 01/2014
1	Bevacizumab (Avastin)FDA Link 04/2013
1	Metalloproteases (Metalloproteinases)IBA 04/2013
1	matrigelIBA 04/2013
1	Radioisotopes (Radionuclides)IBA 06/2011
1	Diphosphonates (Bisphosphonates)IBA 06/2011
1	Biological ProductsIBA 06/2011
1	RANK LigandIBA 06/2011

Therapy/Procedure

3	Therapeutics 10/2020 - 06/2011
1	Stem Cell Transplantation 01/2022
1	Transplantation 01/2022
1	Immunotherapy 01/2019
1	Drug Therapy (Chemotherapy) 01/2018
1	Intravenous Infusions 01/2018
1	Adjuvant Chemotherapy 01/2014
1	Radiotherapy 01/2014